In a significant step toward advancing healthcare education, Guru Kashi University has formalised a strategic partnership with Apollo Knowledge through the signing of a Memorandum of Understanding (MoU). The collaboration reflects a shared commitment to preparing the next generation of healthcare professionals through a blend of academic excellence, industry expertise, and experiential learning.  As healthcare systems continue to evolve, the demand for highly skilled professionals with both theoretical knowledge and practical competencies is growing rapidly. This partnership aims to bridge that gap by providing students with specialised training, industry exposure, and hands-on learning opportunities aligned with contemporary healthcare needs. By integrating real-world healthcare perspectives into academic programmes, the initiative will enable learners to develop critical clinical, technological, and professional skills required in modern healthcare environments. Students will benefit from enhanced exposure to industry best practices, helping them build the confidence and capabilities needed to succeed in diverse healthcare roles. The collaboration also underscores the importance of stronger industry-academia engagement in shaping a future-ready workforce. By fostering innovation, knowledge exchange, and applied learning, Apollo Knowledge and Guru Kashi University are creating meaningful pathways for talent development and healthcare excellence. As the healthcare landscape becomes increasingly complex and technology-driven, such strategic partnerships will play a vital role in nurturing skilled professionals who can contribute to improved patient outcomes and the long-term advancement of healthcare delivery.

Apollo Hospitals Indore has achieved a significant milestone in cardiovascular research by enrolling the first patient from India into the India arm of the prestigious Global SPARX Study. The Global SPARX Study is an international cardiovascular clinical trial designed to evaluate treatment strategies for complex and small coronary artery disease. By comparing contemporary interventional approaches across diverse patient populations, the study aims to generate high-quality evidence that can help inform future treatment guidelines and improve long-term patient outcomes worldwide.   This landmark achievement marks an important step toward strengthening India’s role in global cardiovascular research while advancing evidence-based cardiovascular care through the improved representation of Indian patient populations in the development of future treatment strategies. Cardiovascular diseases remain one of the leading causes of morbidity and mortality worldwide, highlighting the need for robust, globally representative clinical evidence. By participating in the Global SPARX Study, Apollo Hospitals Indore joins an international effort to generate high-quality scientific data that can help inform clinical decision-making and improve patient outcomes across diverse populations.  The successful enrolment reflects the collaborative efforts of Apollo’s clinical research and interventional cardiology teams, whose commitment to research excellence continues to drive innovation in patient care. Participation in global clinical trials not only expands access to advanced research opportunities but also reinforces the importance of evidence-based medicine in addressing complex cardiovascular health challenges. As Apollo Hospitals continues to advance clinical innovation, this milestone underscores its dedication to generating meaningful research insights, fostering medical progress, and delivering world-class care grounded in science, expertise, and patient trust.

Apollo Hospitals, Greams Road, Chennai, has marked a landmark achievement in robotic surgery with Dr. N. Ragavan, Senior Consultant Urologist, Uro-Oncologist and Robotic Surgeon, successfully completing 1,500 da Vinci robotic-assisted procedures. With this milestone, he becomes the first surgeon within the Apollo Hospitals Group in India to reach this remarkable benchmark, underscoring his pioneering contribution to robotic urological surgery and advanced cancer care.  Over the years, Dr. Ragavan has played a pivotal role in advancing robotic-assisted surgery in the region, helping establish one of the country’s leading robotic urology programmes. His expertise in managing complex urological cancers and disorders through minimally invasive techniques has enabled thousands of patients to benefit from highly precise surgical interventions with improved outcomes. Robotic-assisted surgery offers enhanced precision, superior visualisation and greater surgical control, allowing surgeons to perform complex procedures with increased accuracy. For patients, this often translates into reduced postoperative pain, shorter hospital stays, faster recovery and an earlier return to normal life. The milestone also reflects Apollo Hospitals Chennai’s continued commitment to innovation and excellence in surgical care. By investing in advanced robotic platforms and fostering specialised clinical expertise, the hospital remains at the forefront of technology-enabled healthcare and minimally invasive treatment. As robotic surgery continues to redefine the future of healthcare, Apollo Hospitals Chennai remains focused on delivering world-class clinical outcomes through evidence-based practice, cutting-edge technology and patient-centred care. Dr. Ragavan’s achievement not only represents a personal milestone but also highlights Apollo’s leadership in advancing robotic surgery and transforming patient care in India.

Apollo Hospitals proudly celebrates a remarkable milestone in Indian oncology as Padma Shri Dr. P. Vijay Anand Reddy, Director, Apollo Cancer Centre, Hyderabad, has been honoured with the Lifetime Achievement Award by American Society of Clinical Oncology (ASCO). He is listed amongst “Best of ASCO India 2026”. The prestigious recognition acknowledges his enduring contributions to cancer care, clinical leadership, and unwavering commitment to improving patient outcomes.  Over several decades, Dr. Reddy has played a pivotal role in advancing evidence-based cancer treatment in India. His work has helped shape modern oncology practices through a combination of clinical excellence, multidisciplinary care, and a patient-centred approach. Beyond treatment innovations, he has been instrumental in mentoring generations of oncologists and fostering a culture of continuous learning and research. The award reflects not only his professional accomplishments but also the profound impact he has had on countless patients and families navigating the challenges of cancer. His dedication to delivering compassionate care alongside cutting-edge treatment has earned the trust and respect of peers, caregivers, and patients alike. As cancer care continues to evolve through research, technology, and precision medicine, leaders such as Dr. Vijay Anand Reddy exemplify the values that drive meaningful progress in healthcare. Apollo Hospitals congratulates him on this well-deserved honour and celebrates his extraordinary legacy of service, innovation, and hope in the fight against cancer.

In a remarkable demonstration of clinical excellence and advanced cardiovascular care, interventional cardiology specialists at Apollo Hospitals, Greams Road, Chennai, successfully treated a 73-year-old patient with an exceptionally complex cardiac history. The patient, who had previously undergone multiple heart valve interventions, was admitted after collapsing due to severe cardiac rhythm disturbances and an extremely slow heart rate.  Following a comprehensive evaluation, the multidisciplinary team, led by Dr. Refai Showkathali, Senior Consultant Interventional Cardiologist, diagnosed the patient with Tachy-Brady Syndrome, a condition characterized by alternating episodes of abnormally fast and slow heart rhythms. To restore stable cardiac function, the team implanted a leadless Micra pacemaker, an innovative device designed to regulate heart rhythm while minimizing procedural complexity. What makes this case particularly noteworthy is that the patient now lives with five functioning cardiac prostheses, a rare achievement in contemporary cardiac care. Notably, four of these life-saving cardiac interventions were performed at Apollo Hospitals, reflecting the institution’s long-standing expertise in managing highly challenging cardiovascular conditions. This successful outcome highlights the importance of personalized treatment planning, cutting-edge medical technology, and collaborative specialist care. It also underscores how continuous innovation in interventional cardiology is enabling patients with increasingly complex heart conditions to achieve better clinical outcomes and improved quality of life.

Tamil Nadu has marked a significant advancement in cardiac electrophysiology with the successful completion of the state’s first Pulsed Field Ablation (PFA) procedure for the treatment of Atrial Fibrillation (AF) at Apollo Hospitals, Greams Road, Chennai. The procedure was performed by Dr. Karthigesan AM, Senior Consultant Cardiologist and Electrophysiologist, on a 73-year-old patient with a complex heart rhythm disorder, helping restore normal heart rhythm and significantly improving her symptoms and quality of life.  Building on this success, a second case followed soon after involving a 47-year-old patient with drug-refractory Atrial Fibrillation who had previously undergone mitral valve repair. The use of PFA in this complex clinical scenario further demonstrated the versatility and potential of this next-generation technology in managing challenging arrhythmia cases. Atrial Fibrillation is one of the most common cardiac arrhythmias and is associated with an increased risk of stroke, heart failure, and reduced quality of life. Pulsed Field Ablation represents a new generation of catheter-based treatment that uses precisely controlled electrical pulses to selectively target abnormal cardiac tissue responsible for the arrhythmia while preserving surrounding structures. This tissue-selective approach offers enhanced procedural precision, a favourable safety profile, and the potential for faster recovery compared to conventional ablation techniques. The successful introduction of PFA in Tamil Nadu reflects Apollo Hospitals’ ongoing commitment to bringing globally recognized cardiac innovations closer to patients. By combining advanced technology with specialized clinical expertise, Apollo continues to expand access to evidence-based treatments that improve patient outcomes and elevate standards of cardiovascular care across the region. This milestone reinforces the promise of innovation-driven, patient-centred care in shaping the future of heart rhythm management.

Apollo Speciality Hospitals, Madurai, has successfully performed a scarless Vacuum-Assisted Breast Biopsy (VABB) procedure to remove a benign breast tumor in a 20-year-old woman from Tenkasi, highlighting the growing role of minimally invasive interventions in breast care. The procedure was successfully performed by Dr. KB Santhosh Babu, Consultant – Interventional Radiology and his multidisciplinary team.  The patient had experienced mild pain and swelling in her left breast for four months. Following an ultrasound examination, she was diagnosed with fibroadenoma, a common benign breast tumour, and referred to Apollo Hospitals for advanced management. To avoid conventional surgery and achieve a superior cosmetic outcome, Dr. KB Santhosh Babu recommended a VABB procedure. Performed under ultrasound guidance and local anesthesia, the image-guided procedure enabled precise localisation and complete removal of the breast lump through a tiny skin incision. The intervention was completed successfully without any intraoperative or post-procedural complications, allowing the patient to benefit from a scar-free treatment experience. VABB is an advanced, minimally invasive technique designed for the removal of selected benign breast lesions. Compared to traditional open surgery, it offers several advantages, including minimal scarring, preserving breast aesthetics, reduced pain, shorter recovery time, faster return to daily activities, and excellent cosmetic outcomes.   This successful case highlights Apollo Hospitals’ commitment to combining clinical expertise with innovative, evidence-based technologies that enhance patient comfort, improve outcomes, and support personalised breast care for women. 

In a significant step towards strengthening emergency healthcare delivery, Apollo Hospitals has launched Chennai’s largest network of SMART Advanced Cardiac Life Support (ACLS) Ambulances, enhancing the city’s pre-hospital critical care capabilities. The fleet was inaugurated at Apollo Specialty Hospitals, Vanagaram by Thiru P. Rhevanth Charan, MLA, Maduravoyal Constituency, reinforcing Apollo’s commitment to ensuring timely, technology-enabled emergency care when every second matters.  Designed as “ICUs on Wheels”, the SMART ACLS ambulances are equipped with advanced life-support systems and real-time digital connectivity that links onboard emergency teams with hospital specialists during transit. This integrated model enables continuous patient monitoring, secure transmission of vital clinical data, and physician-guided interventions before the patient reaches the hospital. The initiative addresses the growing demand for emergency medical services across Chennai.   Managed through Apollo’s Central Operations Command Centre, the network combines ambulance tracking, teleconsultation, and real-time clinical decision-making to support faster, coordinated emergency responses. By extending specialist-led care beyond hospital walls, Apollo Hospitals continues to advance patient outcomes and redefine the future of emergency medicine through innovation, connectivity, and clinical excellence.

Cancer care is rapidly evolving, with precision oncology and immunotherapy transforming outcomes for patients worldwide. Reflecting this progress, Dr. Jyoti Bajpai, Lead – Medical & Precision Oncology at Apollo Hospitals, Navi Mumbai, has been recognized for “Excellence in Precision Oncology” and featured on the cover of a special edition of Femina magazine, recognizing influential women leaders in healthcare. With over 20 years of experience in medical oncology, Dr. Jyoti Bajpai has been instrumental in advancing precision cancer care, delivering personalized treatment approaches for complex and diverse cancer types. A globally recognized researcher and thought leader, she has made significant contributions to precision medicine, immuno-oncology, and equitable cancer care through pioneering research, international collaborations, and scientific publications. Her work continues to combine cutting-edge innovation with compassionate, patient-centred care, helping improve outcomes for cancer patients worldwide. This recognition highlights the importance of clinical innovation, research excellence, and multidisciplinary expertise in shaping the future of oncology. As cancer treatment becomes increasingly personalized, leaders such as Dr. Bajpai are bringing more targeted therapies, improved quality of life, and renewed hope to individuals and families navigating cancer. At Apollo Hospitals, this commitment to advancing evidence-based, patient-first cancer care remains central to delivering better outcomes and transforming lives. 

Strengthening its commitment to accessible, patient-centric healthcare, Apollo Hospitals has launched a new super-speciality centre in Dadar, Mumbai, aimed at improving access to advanced medical care for patients requiring specialised and long-term treatment. The Apollo Super-Speciality Centre offers integrated services across cardiology, neurology, oncology, gastroenterology, orthopaedics, transplantation, and pulmonology, supported by advanced diagnostics, robotics-enabled care, and 24x7 clinical access.  The initiative addresses a significant patient need in Mumbai, where nearly 8,000 patients travel annually to Apollo Hospitals Navi Mumbai for specialised treatment and follow-up care. By bringing expert-led services closer to central Mumbai, the Dadar facility is expected to reduce travel burden by nearly 30 km per visit for many patients, particularly those undergoing cancer treatment, post-transplant recovery, or chronic disease management. The launch was attended by Mr. Arunesh Punetha, Regional CEO – Western Region, along with Apollo experts including Dr. Anil D’Cruz, Director Oncology and Senior Head and Neck Oncology Surgeon; Dr. Deepak Gautam, Senior Consultant Orthopaedic and Robotic Joint Replacement Surgeon; Dr. Dipalee Borade, Consultant Radiation Oncology; Dr. Jyoti Bajpai, Lead Consultant, Medical and Precision Oncology; and Dr. Sumeet Pawar, Consultant Spine and Neurosurgeon, along with members of the community. Speaking at the launch, Dr. Anil D’Cruz highlighted that the expansion reflects Apollo’s focus on ensuring consistent access to trusted specialists, integrated treatment pathways, and continuity of care closer to patients’ homes. The new centre further strengthens Apollo Hospitals’ vision of delivering evidence-based, multidisciplinary healthcare through a connected ecosystem that prioritises patient outcomes, convenience, and long-term wellness. 

Dr. Raj B Singh, Senior Consultant in Respiratory Medicine at Apollo Hospitals, Chennai, has been honoured with a prestigious Lifetime Achievement Award in recognition of his longstanding contributions to pulmonary and respiratory medicine at the Apollo Thoracic Interventions Conference (ATICON) 2026. The recognition celebrates his decades of dedication to advancing respiratory healthcare, medical education, and evidence-based clinical practice.  With decades of experience, Dr. Singh has been instrumental in advancing the diagnosis and treatment of complex respiratory conditions, including asthma, COPD, pleural diseases, and respiratory infections. Widely respected for his clinical expertise and commitment to evidence-based care, he has also contributed significantly to medical research, academic teaching, and professional societies in respiratory medicine. The recognition reflects Dr. Singh’s enduring impact on patient care and medical excellence, while reinforcing Apollo Hospitals’ commitment to fostering clinical leadership, innovation, and globally benchmarked healthcare outcomes. His association with leading professional bodies, including the Indian Chest Society and the British Thoracic Society, reflects his commitment to advancing respiratory medicine globally.   The honour underscores Apollo Hospitals’ continued commitment to clinical excellence, innovation-led healthcare, and nurturing specialists whose work creates a meaningful impact on patient outcomes and the broader healthcare ecosystem.

Apollo Hospitals has launched a dedicated Centre for Venous Disorders at Apollo One, Greams Road, Chennai, aimed at delivering comprehensive and patient-centric care for a wide range of venous conditions. The centre brings together vascular specialists, diagnostic expertise, and advanced minimally invasive treatment approaches to improve long-term patient outcomes.  Senior consultants and vascular surgeons, Dr. Balaji V and Dr. Rajarajan Venkatesan, emphasised the importance of early detection and timely intervention in managing venous diseases effectively. The centre offers advanced diagnosis and treatment for conditions such as varicose veins, deep vein thrombosis (DVT), venous ulcers, and chronic venous insufficiency, with a focus on faster recovery and seamless follow-up care. The launch event was attended by Dr. Ilankumaran Kaliamoorthy, CEO, Apollo Hospitals Chennai Region; Dr. Anil BG, DMS, Apollo Hospitals Cluster 1, Chennai; Mr. Naveen, CEO, Apollo Hospitals, Greams Road, Chennai; along with members of the clinical leadership team, reinforcing Apollo Hospitals’ continued commitment to specialised, innovation-led vascular care.